Understanding the Relationship Between Muscle Mechanics and Energy Metabolism: A Key to Cardiac and Muscle Disease Research
In the fields of cardiovascular disease and muscle physiology, understanding the relationship between muscle mechanical performance and energy metabolism is critical for uncovering disease mechanisms and developing new therapies. As high energy-demand tissues, the contraction of cardiac muscle, skeletal muscle, and the diaphragm depends on a continuous supply of ATP. Any changes that impair energy efficiency can lead to functional disorders. In recent years, scientists have increasingly relied on advanced experimental tools to precisely measure the mechanical properties and ATP consumption of muscle fibers, thereby gaining deeper insights into the molecular mechanisms underlying muscle diseases.
The 1415A Permeabilized Muscle Fiber ATPase System from Aurora Scientific is a cutting-edge instrument designed for this purpose. By simultaneously measuring the mechanical performance and ATP consumption of permeabilized muscle fibers, it provides researchers with comprehensive data on mechano-metabolic coupling. This article presents the technical features of the 1415A system and its application in studies of cardiac muscle, skeletal muscle, and the diaphragm.
Overview of the 1415A System
The 1415A Permeabilized Muscle Fiber ATPase System is purpose-built for muscle physiology research. It enables seamless measurement of the mechanical properties and ATP consumption of permeabilized (skinned) muscle fibers on a single user-friendly platform. Using the Absorbance Technique to monitor ATP hydrolysis rate, combined with high-precision mechanical measurements, the system offers powerful support for studying cardiac, skeletal, and diaphragmatic muscle function.
Key Features
Mechanical Performance Measurement: Quantifies muscle fiber contractile force, length changes, and calcium sensitivity.
ATP Consumption Measurement: Monitors ATP hydrolysis rate in real time through an enzymatic cascade (PK, LDH).
Automated Control: Features automatic indexing of bath plate and supports pre-programmed calcium concentrations and activation/relaxation sequences.
Temperature Control: Maintains physiological temperatures (0–40°C) during experiments.
Microscope Compatibility: Can be directly mounted on an inverted microscope for combined structural observation.
Technical Highlights
Dual Measurement Capability: Simultaneous real-time measurement of mechanical performance and ATP consumption, providing comprehensive data on mechano-metabolic coupling.
High Accuracy: Direct measurement of ATP consumption avoids the errors of indirect methods.
User-Friendly: Automated control and pre-programmed sequences reduce operational complexity.
Versatile Applications: Suitable for research on cardiac, skeletal, and diaphragmatic muscles across various disease models.
Applications in Muscle Research
The 1415A system has demonstrated broad application potential in research on cardiac muscle, skeletal muscle, and the diaphragm. The following are several representative cases based on published literature:
Cardiac Muscle Research
Case 1: Heart Failure and β-MHC Expression
Background: In heart failure, cardiac muscle shifts from expressing α-myosin heavy chain (α-MHC) to β-MHC, affecting energy metabolism and contraction speed.
Findings: Increased β-MHC expression reduced ATPase activity from 395 ± 25 peals⁻¹ mass to 218 ± 24 peals⁻¹ mass (P < 0.01) and decreased tension cost from 6.7 ± 0.4 to 3.9 ± 0.3 (P < 0.01), indicating increased energy efficiency but slower cross-bridge cycling.
1415A System Role: Measured the mechanical performance and ATP consumption of right ventricular trabeculae, revealing the impact of MHC isoform shifts on cardiac function.
Significance: Provides a basis for developing therapies aimed at modulating MHC expression.
Case 2: Myocardial Infarction and cMyBP-C Fragments
Background: After myocardial infarction, cardiac myosin binding protein C (cMyBP-C) is cleaved, producing an N-terminal fragment (hCOC1f) that affects myofilament function.
Findings: hCOC1f reduced maximum force and calcium sensitivity, increased ATPase activity, and elevated tension cost, especially at shorter sarcomere lengths (2 μm).
1415A System Role: Assessed the mechanical performance and ATP consumption of cardiac myofibrils to evaluate the impact of hCOC1f.
Significance: Sheds light on the mechanism of post-infarction dysfunction and suggests the therapeutic potential of preventing cMyBP-C cleavage.
Case 3: Nemaline Myopathy
Background: Nemaline myopathy is caused by mutations in thin filament genes (e.g., NEB, ACTA1), leading to muscle weakness.
Findings: Troponin activator CK-2066260 enhanced force generation at submaximal calcium levels in NEB mutation carriers; novel ACTA1 mutations were associated with late-onset disease and abnormal nuclear structures.
1415A System Role: Measured the mechanical properties and ATP consumption of permeabilized muscle fibers from patients to evaluate therapeutic potential.
Significance: Supports the development of drugs that enhance calcium sensitivity.
Case 4: Mechanism of Cardiac Relaxation
Background: Relaxation of cardiac muscle is critical for diastolic function and is influenced by rapid stretch.
Findings: End-systolic strain rate (rapid re-lengthening) rather than afterload determined the rate of myocardial relaxation.
1415A System Role: Measured the mechanical properties of cardiac trabeculae to analyze relaxation kinetics.
Significance: Offers new insights for the treatment of diastolic dysfunction.
Skeletal Muscle Research
Case 5: Diabetes and Muscle Quality
Background: Elderly diabetic patients experience muscle quality decline, accompanied by increased extracellular matrix (ECM) deposition.
Findings: Passive stiffness of gluteus maximus fibers increased due to ECM accumulation, with a significant rise in type I fiber proportion.
1415A System Role: Evaluated the mechanical properties and ATP consumption of single muscle fibers to assess passive tension.
Significance: Highlights diabetes-induced muscle alterations and informs rehabilitation strategies.
Case 6: Eccentric Force in Slow-Twitch Fibers
Background: Stretch velocity affects eccentric force generation in slow-twitch fibers.
Findings: At stretch velocities of 0.01, 0.1, and 1 vmax, the “give” of slow-twitch fibers was 7%, 18%, and 44% of maximal isometric force, with force increasing nearly linearly in the second half of stretch.
1415A System Role: Measured force generation and ATP consumption in single soleus muscle fibers.
Significance: Enhances understanding of slow fiber mechanics, with applications in sports and rehabilitation.
Case 7: Fast Muscle MyBP-C Knockout
Background: Deletion of fast skeletal MyBP-C affects myofibrillar structure and length-dependent activation.
Findings: C2−/− fibers showed reduced force generation and calcium sensitivity, with myosin heads shifted toward actin filaments.
1415A System Role: Combined with small-angle X-ray diffraction to assess myofibril mechanics and ATP consumption.
Significance: Reveals the role of MyBP-C in regulating muscle contraction.
Diaphragm Research
Case 8: Diaphragm Weakness in Pulmonary Hypertension
Background: Pulmonary hypertension (PH) leads to diaphragm weakness, impairing respiratory function.
Findings: In PH rats, maximum tension of type 2X and 2B diaphragm fibers was reduced by 20%, with unchanged tension cost. Reduced myosin heavy chain content accounted for diminished force generation.
1415A System Role: Measured the contractile performance and ATP consumption of skinned diaphragm fibers to uncover myofilament dysfunction.
Significance: Identifies therapeutic targets for respiratory muscle dysfunction in PH patients.
Why Studying ATP Consumption Is Critical
ATP is the direct energy source for muscle contraction, particularly vital in the energy-demanding cardiac muscle. Skeletal muscle and the diaphragm also rely on ATP during physical activity and respiration. The importance of studying ATP consumption lies in the following:
Uncovering Disease Mechanisms: In conditions like heart failure, myocardial infarction, muscle atrophy, and diaphragmatic weakness, reduced ATP utilization efficiency leads to dysfunction.
Guiding Therapeutic Development: Enhancing ATP utilization can improve muscle performance. For instance, modulating MHC isoforms or preventing cMyBP-C cleavage may serve as therapeutic strategies.
Personalized Medicine: Treatment regimens can be tailored based on individual ATP consumption profiles.
Exercise and Rehabilitation: Understanding ATP metabolism in skeletal and respiratory muscles supports the design of more effective training or recovery programs.

Technical Advantages: Comparison with Sxxx XF Analyzer

The Sxxx XF Analyzer represents a widely utilized cellular metabolic analysis instrument, which indirectly evaluates ATP production through the measurement of oxygen consumption rate (OCR). Nevertheless, the 1415A system demonstrates substantial advantages in the following aspects:

Direct Measurement Advantage: The 1415A system directly measures ATP hydrolysis rates, whereas the Sxxx system indirectly infers ATP production through OCR, which cannot accurately reflect energy consumption during muscle contraction.
Mechanics-Metabolism Coupling: The 1415A system simultaneously measures mechanical performance (e.g., contractile force) and ATP consumption, providing comprehensive data on muscle function.
Specialized for Muscle Fibers: Designed specifically for muscle fiber research, the 1415A system is suitable for cardiac, skeletal, and diaphragm muscles, while the Sxxx system is more appropriate for whole-cell metabolic analysis.
User-Friendly: The 1415A system features automated controls and temperature regulation, reducing experimental complexity.
High Precision: Direct measurement by the 1415A system eliminates the errors associated with indirect inference in the Sxxx system, making it particularly suitable for studying muscle energy efficiency.
Future Directions: 

The potential of the 1415A system in muscle research continues to expand, with future applications including:
Drug Development: Testing drugs targeting cardiomyopathy, muscle atrophy, and diaphragm weakness to evaluate their effects on energy metabolism.
Personalized Medicine: Tailoring treatment plans based on individual muscle function.
Aging Research: Investigating mechanisms of age-related degeneration in cardiac, skeletal, and diaphragm muscles.
Exercise Physiology: Studying the effects of exercise on energy metabolism and mechanical performance in cardiac, skeletal, and diaphragm muscles.
Conclusion: 

Aurora Scientific's 1415A Permeabilized Muscle Fiber ATPase System is a revolutionary tool in muscle research. By precisely measuring mechanical performance and ATP consumption in cardiac, skeletal, and diaphragm muscle fibers, it provides scientists with a window into the mechanisms of muscle diseases. Whether it is heart failure, myocardial infarction, nemaline myopathy, muscle atrophy, or diaphragm weakness caused by pulmonary hypertension, the 1415A system demonstrates its immense potential in uncovering disease mechanisms and guiding therapeutic development.
Compared to the Sxxx XF Analyzer, the 1415A system's direct measurement capabilities and mechanics-metabolism coupling analysis make it unique in muscle physiology research. For scientists studying cardiac, skeletal, or diaphragm muscles, the 1415A system is not just a technical tool but a key to new discoveries.